Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Compass 3: A Novel Transition Program to Reduce Disability After a Stroke

NCT07069660 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT07069660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07069660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Compass 3: A Novel Transition Program to Reduce Disability After a Stroke
Lead sponsor
Washington University School of Medicine
Phase
Not applicable
Overall status
Recruiting
Start date
September 29, 2025
Completion date
March 31, 2030
Enrollment
520 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

stroke